Girshick Birgit's Form 4 filing
Charles River Laboratories International, Inc.CRL · filed Nov 21, 2023
- Accession no.
- 0001127602-23-028148
- Filed
- Nov 21, 2023
- Trade date
- Mar 1, 2021-Nov 20, 2023
- Filing delay
- 995 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $248.3K. It was filed 995 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Girshick BirgitCIK 0001732091 | Officer (Corporate Executive VP & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | Common Stock | GGiftDisposed | −350 | $0.00 | $0 | 28,710 | Direct | |
| Nov 20, 2023 | Common Stock | PPurchaseAcquired | +1,322 | $187.82 | +$248,298.04 | 44,449 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.